Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New islet cell transplant procedure offers improved outcomes for patients with type 1 diabetes

20.09.2013
Advanced technique for harvesting insulin-producing cells offers an alternative to transplant surgery

The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.

Participants in the new study received islet cells isolated from the pancreas of organ donors to help their bodies produce insulin, the life-sustaining hormone responsible for absorbing glucose from the blood. The new approach, which allowed the harvested cells a short period of rest prior to transplant, resulted in increased levels of insulin production to the degree that patients were able to discontinue daily insulin injections. Results of the study, conducted by researchers at the Perelman School of Medicine at the University of Pennsylvania, appeared recently in the journal Diabetes.

In the study, investigators used an advanced technique to isolate and harvest islet cells from donor pancreases. Unlike prior methods in which isolated islet cells were immediately transferred to the recipient, the new technique allowed the extracted cells to rest in a controlled environment for three days prior to transplant. Inflammation that occurs when the cells are harvested can often predispose the recipient to rejection after transplantation. However, by allowing the cells to rest, the inflammation – and possibility of rejection – is reduced. Ultimately, the resting period also resulted in a more efficient process by allowing investigators to use fewer islet cells than previous methods which required cells from two or more donor pancreases achieve similar results. Despite fewer islet cells being transplanted, the new approach resulted in significantly improved islet cell function.

"These results show that islet transplantation has become a more promising method for replacing the islet cells in type 1 diabetes patients experiencing severe problems with low blood sugar," said lead author Michael R. Rickels, MD, MS, medical director for the Pancreatic Islet Cell Transplantation Program and associate professor of Medicine in Endocrinology, Diabetes and Metabolism at Penn Medicine. "We've seen positive long-term results with this technique, and are excited to be able to offer the option to our patients, where currently a whole pancreas transplant requiring major surgery is the only available alternative."

The new approach, known as the CIT07 protocol, was developed by the National Institutes of Health and sponsored by the Clinical Islet Transplantation (CIT) Consortium, in which Penn has served as a member since 2004. Under the new protocol, which measures islet cell mass, all patients involved in the study were able to come off insulin therapy and remained so after at least one year with no loss of the transplanted cell mass.

Typically, patients with type 1 diabetes must self-administer multiple injections of insulin per day, or receive it by a continuous infusion from a wearable pump. However, insulin therapy is difficult to calibrate to the body's changing energy needs, and patients are required to frequently check their blood sugar levels and adjust their insulin dosage. Varying levels of insulin in the body often results in low blood sugar (hypoglycemia), which can induce a coma or other medical emergency. Conversely, islet transplantation, when effective, results in natural, internal self-monitoring and adjustment of insulin levels to keep blood sugar levels in a normal range (homeostasis).

"The fact that significantly more transplanted islet cells in the new protocol are able to successfully integrate and continue producing insulin at least one year later compared to prior studies, gives us hope that more type 1 diabetes patients will be able to live full and healthy lives free from the dangers of hypoglycemia and the burden of administering insulin," said senior author and principal investigator Ali Naji, MD, PhD, surgical director of the Kidney and Pancreas Transplant Program at Penn Medicine.

Roughly five to ten percent of all people with diabetes have Type 1 diabetes. Previously known as juvenile-onset diabetes, Type 1 diabetes is typically first diagnosed in children and young adults and persists throughout life. Patients with the disease do not produce insulin because of autoimmune destruction of the insulin producing cells in the pancreas. Without insulin, patients cannot convert sugar, starches, and other food into energy needed for survival. When left untreated, Type 1 diabetes is a potentially fatal disease.

Penn Medicine is one of the world's leading academic medical centers, dedicated to the related missions of medical education, biomedical research, and excellence in patient care. Penn Medicine consists of the Raymond and Ruth Perelman School of Medicine at the University of Pennsylvania (founded in 1765 as the nation's first medical school) and the University of Pennsylvania Health System, which together form a $4.3 billion enterprise.

The Perelman School of Medicine has been ranked among the top five medical schools in the United States for the past 16 years, according to U.S. News & World Report's survey of research-oriented medical schools. The School is consistently among the nation's top recipients of funding from the National Institutes of Health, with $398 million awarded in the 2012 fiscal year.

The University of Pennsylvania Health System's patient care facilities include: The Hospital of the University of Pennsylvania -- recognized as one of the nation's top "Honor Roll" hospitals by U.S. News & World Report; Penn Presbyterian Medical Center; Chester County Hospital; Penn Wissahickon Hospice; and Pennsylvania Hospital -- the nation's first hospital, founded in 1751. Additional affiliated inpatient care facilities and services throughout the Philadelphia region include Chestnut Hill Hospital and Good Shepherd Penn Partners, a partnership between Good Shepherd Rehabilitation Network and Penn Medicine.

Penn Medicine is committed to improving lives and health through a variety of community-based programs and activities. In fiscal year 2012, Penn Medicine provided $827 million to benefit our community.

Katie Delach | EurekAlert!
Further information:
http://www.uphs.upenn.edu

More articles from Health and Medicine:

nachricht 3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg

nachricht Better equipped in the fight against lung cancer
16.05.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Explanation for puzzling quantum oscillations has been found

So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics

Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...

Im Focus: Dozens of binaries from Milky Way's globular clusters could be detectable by LISA

Next-generation gravitational wave detector in space will complement LIGO on Earth

The historic first detection of gravitational waves from colliding black holes far outside our galaxy opened a new window to understanding the universe. A...

Im Focus: Entangled atoms shine in unison

A team led by Austrian experimental physicist Rainer Blatt has succeeded in characterizing the quantum entanglement of two spatially separated atoms by observing their light emission. This fundamental demonstration could lead to the development of highly sensitive optical gradiometers for the precise measurement of the gravitational field or the earth's magnetic field.

The age of quantum technology has long been heralded. Decades of research into the quantum world have led to the development of methods that make it possible...

Im Focus: Computer-Designed Customized Regenerative Heart Valves

Cardiovascular tissue engineering aims to treat heart disease with prostheses that grow and regenerate. Now, researchers from the University of Zurich, the Technical University Eindhoven and the Charité Berlin have successfully implanted regenerative heart valves, designed with the aid of computer simulations, into sheep for the first time.

Producing living tissue or organs based on human cells is one of the main research fields in regenerative medicine. Tissue engineering, which involves growing...

Im Focus: Light-induced superconductivity under high pressure

A team of scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg investigated optically-induced superconductivity in the alkali-doped fulleride K3C60under high external pressures. This study allowed, on one hand, to uniquely assess the nature of the transient state as a superconducting phase. In addition, it unveiled the possibility to induce superconductivity in K3C60 at temperatures far above the -170 degrees Celsius hypothesized previously, and rather all the way to room temperature. The paper by Cantaluppi et al has been published in Nature Physics.

Unlike ordinary metals, superconductors have the unique capability of transporting electrical currents without any loss. Nowadays, their technological...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

Save the date: Forum European Neuroscience – 07-11 July 2018 in Berlin, Germany

02.05.2018 | Event News

Invitation to the upcoming "Current Topics in Bioinformatics: Big Data in Genomics and Medicine"

13.04.2018 | Event News

Unique scope of UV LED technologies and applications presented in Berlin: ICULTA-2018

12.04.2018 | Event News

 
Latest News

Supersonic waves may help electronics beat the heat

18.05.2018 | Power and Electrical Engineering

Keeping a Close Eye on Ice Loss

18.05.2018 | Information Technology

CrowdWater: An App for Flood Research

18.05.2018 | Information Technology

VideoLinks
Science & Research
Overview of more VideoLinks >>>